(Chapel Hill, NC) April 11, 2018 –  Title:  Reflections on the Early Stages of Creative Disruption in the Clinical Trial Site Sector and the Tipping Point now finally upon us

By Barry Lake, CEO & Co-Founder, Devana Solutions®

Last Wednesday, April 11, 2018 we were proud to issue a joint press release with the Association of Clinical Research Professionals for the ACRP-Devana Solutions® 1^st Annual Site Metrics Challenge Study.

We are very honored to work with ACRP and three of our valuable site organization partner-clients, IACT Health, LMC I Manna Research, and PMG Research, to analyze site and network timing and performance metrics data relative to clinical site staff training and development initiatives. The year-long Study in support of ACRP’s clinical trials workforce development goals will kick off at the ACRP Expo on April 27 – 30 in the D.C. area (https://devanasolutions.com/04112018-acrp-and-devana-solutions-launch-first-annual-site-metrics-challenge-study/). The upcoming Expo will mark just the second anniversary since Devana Solutions® first launched commercially at the ACRP Expo in Atlanta in April 2016 with our inaugural cloud-based Site Operations Management Software offering now called IGNITE FOR SITES. As a result, the announcement gave me pause to reflect.

What has changed since our upstart tech company embarked upon our quest to bring data transparency to the fragmented and opaque clinical trial site sector where the real work of clinical trials – seeing actual volunteer patient-subjects – truly happens?

It seems like just recently the pharmaceutical industry turned its full attention to efforts to streamline study start-up in a quest to reduce overall trial cycle time and costs. If reducing study start-up time is critical to cutting costs to advance new therapies, then doesn’t it stand to reason that the industry would rapidly gravitate towards those trial sites and site network organizations that employ Devana Solutions® advanced technology? The platform provides cross-functional teams at those early-adopting trial sites and networks with organization-wide transparency into each milestone and pain point in trial start-up so that responsible staff can rapidly mobilize to address bottlenecks and delays in order to clear the way for the important work of patient recruitment and screening? Further, shouldn’t trial sites and networks rapidly embrace such a system to allow their leadership to drive operational improvements to combat recurring start-up hurdles? What if the same advanced system also automatically captured critical site timing and performance metrics allowing those site and network leaders to easily prove their trial management expertise in their chosen therapeutic strengths?

In a drug development industry that is notoriously slow to adopt change, our young company’s efforts at creative disruption through these technological innovations targeting the clinical trial site sector have, admittedly, not inspired a tsunami of industry Sponsor, CRO or site sector demand…until now.

With gratitude to the former INC Research’s, now Syneos Health’s visionary Catalyst Program which continues to forge ahead past usual resistance, the April 11, 2018 announcement of the ACRP – Devana Solutions® 1^stAnnual Metrics Challenge Study may well stand as the “tipping point” for our data transparency platform to align top-performing research sites with Sponsors and CROs to reduce drug development costs and cure disease. What gives me confidence to put forward such a claim?

With a nod to Mr. Gladwell’s 3 Rules of Epidemics; specifically, “The Law of the Few” which, in economic terms, manifests itself in the “80/20 Principle or, the idea that in any situation roughly 80% of the ‘work’ will be done by 20% of the participants”, I have recently been sending notes of thanks and taking the opportunity in my daily interactions to thank all of the “connectors”, “mavens” (information specialists) and “salespeople” whom all continue to be tireless advocates of our Devana Solutions® technology. I have been humbled to point out the following to them:

Right now, 3 of the Top 5 Largest Integrated Site Networks or Organizations in the world have embraced the Devana Solutions® IGNITE FOR SITES platform. PMG Research, IACT Health and LMC I Manna Research stand as industry-leaders in the clinical trials site sector. These 3 organizations have the confidence in their capabilities and vision to embrace our platform and leverage data analytics to further improve what are already efficient site operations. I have no doubt this will propel their site organizations even further ahead of their competitors in clinical trial management and execution.

ABOUT DEVANA SOLUTIONS LLC:

Devana Solutions®, LLC is a SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana Solutions® offers two platforms, IGNITE FOR SITES, an advanced operations and data analytics technology for sites and site networks and MATCH PERFORMANCE, to provide historical and real-time data capture, aggregation and display to drug development stakeholders. To learn more visit https://devanasolutions.com.

CONTACT:

Matt Smith, Executive Director, Strategic Partnerships

msmith@devanasolutions.com

(608) 285-2151

(Chapel Hill, NC) April 2, 2018  – In Collaboration with Industry-Leading Site Networks

Washington, DC – The Association of Clinical Research Professionals, a non-profit setting standards for clinical research competence and workforce development, and Devana Solutions today announce an initiative to analyze research site and network performance data based on workforce qualification.

The study will analyze site and network timing and performance metrics data relative to clinical site staff training and development initiatives.

The year-long study, known as the 2018-2019 Annual Site Metrics Challenge Study, will be headlined by three industry-leading integrated site networks, including: IACT Health, a 10-site network throughout Georgia; LMC|Manna Research, an 18-site network across Canada; and PMG Research, Inc., a network of 14 integrated sites based in North Carolina and operating in the Mid-Atlantic & Midwest regions.

“In support of ACRP’s workforce development goals, we believe it is critical to analyze site staffing, training, and development training initiatives and their impact on performance,” says Jim Kremidas, ACRP Executive Director. “Since Devana Solutions’ software helps sites capture key metrics for display and analysis, it is a natural fit to collaborate with them on the study.”

“Our industry is notoriously slow to change,” adds Barry Lake, CEO of Devana Solutions, “but it’s starting to realize the need for data and analytics to improve clinical trial efficiency. Now, with industry-leading site networks such as PMG Research, LMC-Manna Research, and IACT Health having embraced our technology to drive operational analysis and improvement, it was a given to have these three leading organizations headline the first Annual Site Metrics Challenge Study.”

“Making the clinical research community stronger is central to ACRP and a core value shared by all leaders in the clinical trials industry,” stated Dr. Jeff Kingsley, CEO, IACT Health, “we are pleased to headline this effort with our industry peers.”

“Training and continuing education have always been central at LMC|Manna Research,” says Karri Venn, President, Research, “and we’ve always been supportive of ACRP’s efforts in raising the standards in the professional development of those involved in clinical research. We applaud ACRP and Devana Solutions in studying performance in such a holistic way and are excited to participate.”

“PMG Research has always embraced technology innovation as an important way to develop our business and fulfil our goal of bringing clinical research to as many people as possible,” says Kathy Cole, PMG’s Associate Director of Feasibility, “so helping lead this study for ACRP and Devana Solutions is a perfect fit.”

The ACRP – Devana Solutions Annual Site Metrics Challenge Study kicks off at the ACRP 2018 annual conference, April 27-30 at National Harbor, MD, just outside Washington, DC, and continues through the ACRP 2019 annual conference. Visit Devana Solutions at ACRP 2018 in Booth 304 to learn more and sign up.

Every research site or network using Devana Solutions’ IGNITE FOR SITES operational platform is encouraged to participate. Site and network category leaders will be recognized at ACRP 2019 in Nashville, TN.

For sites interested in participating but not yet benefitting from the IGNITE FOR SITES technology, Devana Solutions will be running promotional pricing and incentives from now through ACRP 2018.

About ACRP

ACRP supports clinical research professionals through membership, training and development, and certification. Founded in 1976, ACRP is a Washington, DC-based nonprofit organization with more than 13,000 members who work in clinical research in more than 70 countries. ACRP’s vision is that clinical research is performed ethically, responsibly, and professionally everywhere in the world. ACRP’s mission is to promote excellence in clinical research. www.acrpnet.org

About Devana Solutions

Devana Solutions®, LLC is a SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana Solutions® offers two platforms, IGNITE FOR SITES and MATCH PERFORMANCE, to provide historical and real-time data capture, aggregation and display to drug development stakeholders. www.devanasolutions.com

Devana Solutions CONTACT:
Cindy Tremblay
+ 1.843.805.4039
ctremblay@devanasolutions.com

(CHARLESTON, SC) November 29th, 2017 — Iact Health has just become the latest network of clinical research sites to take advantage of Devana Solutions® IGNITE FOR SITES advanced central data analytics technology for clinical trial sites. The decision puts the 12-year old network of sites in good company as many of the industry leading sites and networks that have adopted Devana’s IGNITE can report not only their historical performance metrics but can also capture and deliver their site timing and performance metrics to Sponsors and CROs in real time. This will enable Iact Health and other leading trial site networks on IGNITE FOR SITES to align therapeutically and operationally with those Sponsors or CROs seeking to conduct clinical trials where Iact’s performance is second to none.

“Ultimately, this alignment between the top trial sites, Sponsors and CROs through Devana Solutions technology is at the heart of our mission,” explains Barry Lake, Devana’s CEO. “The greatest impact we can make on lowering drug development costs is through cutting clinical trial cycle times and our platform aims to do just that.”

“Prior to implementing Devana Solutions IGNITE FOR SITES system, we were struggling to effectively track our site metrics through a combination of our CTMS (Clinical Trial Management Software) and a myriad of Excel Spreadsheets,” states Felicia Irvin, Vice President of Sales and Marketing at Iact Health. “Now, the Devana technology, has everything in one centralized place and we can quickly and efficiently access our site’s performance metrics to analyze and complete a Sponsor Feasibility questionnaire in minutes.”

Iact Health is an integrated network of 10 strong investigative sites with a wealth of clinical trial experience in over 25 therapies with particular strength in Pulmonary Disease, Infectious Disease and Dermatology. Led by Dr. Jeff Kingsley, a clinical trial industry leader, and headquartered in Columbus, Georgia, Iact Health has completed well over 300 studies. Over 100 Physician Investigators have conducted studies with the Iact Health site network and the group employs 11 full-time Clinical Research Coordinators (CRC). Iact has won awards ranging from “Top 10 Best Places to Work in Georgia” according to Georgia Trend Magazine (2009), the “Psychologically Healthy Workplace Award” from the Georgia Psychological Association (2012) and more recently, the “Rockstar Award” as bestowed by the Georgia Department of Economic Development (2016).

ABOUT IACT HEALTH:

IACT Health is a wholly owned clinical research company staffed entirely by specialists. Our specialists range from patient coordinator specialists to regulatory specialists to disease specialists. Across Georgia, our staff applies the highest level of expertise to conduct studies in Pharmaceutical, Biotech and Medical Devices industries. We pride ourselves on providing the highest level of quality care for patients, and our guarantee of optimal results for CROs, Sponsors, and physicians.

ABOUT DEVANA SOLUTIONS LLC:

Devana Solutions®, LLC is a SaaS provider driven by a core belief that data transparency through technology is key in selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana Solutions® offers two platforms, IGNITE FOR SITES and MATCH PERFORMANCE, to provide historical and real-time data capture, aggregation and display to drug development stakeholders. To learn more visit https://devanasolutions.com.

FOR FURTHER INFORMATION, PLEASE CONTACT:

For Devana Solutions, LLC:

Emily Wike

ewike@devanasolutions.com

For Iact Health

Felicia Irvin

Tel: 706-596-5425

firvin@iacthealth.com